99% Savings - Buy Just @1 Rs X
Twintel CH 6.25 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Twintel CH 6.25 Tablet have also been mentioned below.
The right dosage of Twintel CH 6.25 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Twintel CH 6.25 Tablet are Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Twintel CH 6.25 Tablet as well, which are listed below. These side effects of Twintel CH 6.25 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Twintel CH 6.25 Tablet's effect is Mild during pregnancy and Mild for lactating mothers. Further, the section on Twintel CH 6.25 Tablet related warnings talks about Twintel CH 6.25 Tablet's effects on the liver, heart and kidney.
Twintel CH 6.25 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia as it can result in adverse effects. Some other conditions that can be affected by Twintel CH 6.25 Tablet are listed in the contraindications section below.
Drug interactions for Twintel CH 6.25 Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Twintel CH 6.25 Tablet is not safe while driving, and is not addiction.
Twintel CH 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Twintel CH 6.25 Tablet safe for pregnant women?
Twintel CH rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Twintel CH 6.25 Tablet safe during breastfeeding?
Twintel CH has been seen to have minimal side effects on breastfeeding women.
What is the effect of Twintel CH 6.25 Tablet on the Kidneys?
Very few cases of side effects of Twintel CH on kidney have been reported.
What is the effect of Twintel CH 6.25 Tablet on the Liver?
Twintel CH may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Twintel CH 6.25 Tablet on the Heart?
Very few cases of side effects of Twintel CH on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Twintel CH 6.25 Tablet unless your doctor advises you to do so -
Is this Twintel CH 6.25 Tablet habit forming or addictive?
No, you will not get addicted to Twintel CH 6.25 Tablet.
Interaction between Food and Twintel CH 6.25 Tablet
Twintel CH 6.25 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Twintel CH 6.25 Tablet
Taking alcohol with Twintel CH 6.25 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448